The specific inhibitors of p38 MAPK, SB203580 and SB202190, effectively decreased the levels of phosphorylated p38α protein in MX2‐resistant leukemia cells (K562/MX2, BALL/MX2) (Fig. 1). The gene discussed is MX2; the disease is leukemia.